During the past decade, Indiana University Department of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University Department of Neurology" #1 sponsor was "OPKO Health, Inc." with 2 trials, followed by "Artielle ImmunoTherapeutics" with 1 trials sponsored, "CENTOGENE GmbH Rostock" with 1 trials sponsored, "Cytokinetics" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University Department of Neurology" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University Department of Neurology" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials). Many other conditions were trialed in "Indiana University Department of Neurology" in a lesser frequency.

Most popular intervention types in "Indiana University Department of Neurology" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials), "CK-2017357" (1 trials) and "Crenezumab dose level 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University Department of Neurology" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Indiana University Department of Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Indiana University Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University Department of Neurology, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".